Mangoceuticals (MGRX) Assets Average (2023 - 2026)

Mangoceuticals has disclosed Assets Average across 4 years of filings, most recently posting $14.3 million for Q2 2026.

• In Q2 2026, Assets Average fell 32.81% year-over-year to $14.3 million; the TTM figure through Jun 2026 stood at $14.3 million (down 32.81% YoY), while the FY2025 annual figure was $15.7 million, up 91.58% from the prior year.
• Assets Average came in at $14.3 million for Q2 2026 at Mangoceuticals, down from $15.3 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $21.3 million in Q2 2025 to a low of $676120.0 in Q1 2024.
• Average Assets Average over 4 years is $10.9 million, with a median of $14.7 million recorded in 2024.
• Year-over-year, Assets Average sank 73.58% in 2024 and jumped 2645.4% in 2025.
• Over 4 years, Assets Average stood at $1.3 million in 2023, then soared by 1039.8% to $15.1 million in 2024, then advanced by 8.15% to $16.3 million in 2025, then fell by 12.26% to $14.3 million in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $14.3 million in Q2 2026, $15.3 million in Q1 2026, and $16.3 million in Q4 2025.